Citation: | WANG Yazhe, ZHOU Jianping, DING Yang, WANG Wei. Advances in research of biomimetic drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(3): 267-273. DOI: 10.11665/j.issn.1000-5048.20140303 |
[1] |
Stanley S.Biological nanoparticles and their influence on organisms[J]. Curr Opin Biotechnol,2014(28):69-74.
|
[2] |
Roth J,Curiel D,Pereboeva L.Cell vehicle targeting strategies[J]. Gene Ther,2008,15(10):716-729.
|
[3] |
Hamidi M,Zarrin A,Foroozesh M,et al.Applications of carrier erythrocytes in delivery of biopharmaceuticals[J]. J Control Release,2007,118(2):145-160.
|
[4] |
Muzykantov VR.Drug delivery carriers on the fringes:natural red blood cells versus synthetic multilayered capsules[J]. Expert Opin Drug Deliv,2013,10(1):1-4.
|
[5] |
Anbharasi V,Cao N,Feng SS.Doxorubicin conjugated to D-α-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy[J]. J Biomel Mater Res A,2010,94(3):730-743.
|
[6] |
Gopal V,Kumar AR,Usha N,et al.Effective drug targeting by erythrocytes as carrier systems[J]. Curr Trends Biotechnol Pharm,2007,(1):18-33.
|
[7] |
Chambers E,Mitragotri S.Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes[J]. J Control Release,2004,100(1):111-119.
|
[8] |
Chambers E, Mitragotri S. Long circulating nanoparticles via adhesion on red blood cells:mechanism and extended circulation[J]. Exp Biol Med,2007,232(7):958-966.
|
[9] |
Cinti C,Taranta M,Naldi I,et al.Newly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compounds[J]. PLoS One,2011,6(2):e17132.
|
[10] |
Wang LY,Shi XY,Yang CS,et al.Versatile RBC-derived vesicles as nanoparticle vector of photosensitizers for photodynamic therapy[J]. Nanoscale,2013,5(1):416-421.
|
[11] |
Mantovani A,Sozzani S,Locati M,et al.Macrophage polarization:tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes[J]. Trends Immunol,2002,23(11):549-555.
|
[12] |
Peng KW,Dogan A,Vrana J,et al.Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma[J]. Am J Hematol,2009,84(7):401-407.
|
[13] |
Choi MR,Bardhan R,Stanton-Maxey KJ,et al.Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse[J]. Cancer Nanotechnol,2012,3(1-6):47-54.
|
[14] |
Alizadeh D,Zhang L,Hwang J,et al.Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas[J]. Nanomedicine,2010,6(2):382-390.
|
[15] |
Swiston AJ,Cheng C,Um SH,et al.Surface functionalization of living cells with multilayer patches[J]. Nano Lett,2008,8(12):4 446-4 453.
|
[16] |
Stephan MT,Moon JJ,Um SH,et al.Therapeutic cell engineering with surface-conjugated synthetic nanoparticles[J]. Nat Med,2010,16(9):1 035-1 041.
|
[17] |
Kosaka H,Ichikawa T,Kurozumi K,et al.Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma[J]. Cancer Gene Ther,2012,19(8):572-578.
|
[18] |
Bak X, Yang J, Wang S. Baculovirus-transduced bone marrow mesenchymal stem cells for systemic cancer therapy[J]. Cancer Gene Ther,2010,17(10):721-729.
|
[19] |
Huang Q,Liu X,Kang C,et al.The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells[J]. Cancer Gene Ther,2009,17(3):192-202.
|
[20] |
Nakamura K,Ito Y,Kawano Y,et al.Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model[J]. Gene Ther,2004,11(14):1 155-1 164.
|
[21] |
Ren C,Kumar S,Chanda D,et al.汃敡楮捣?慲挠楧摥?摥攠汴楨癥敲牡祰孹?嵵??楮??乭慥湳潥??敨瑹瑭??椠???ねㄠ???扬?ㄠ???扲????????の?????????抲爠??嬠?ㄠ嵭?創敳祥渠潰汲摯獳?????畣污楮正?割匠??坮敧渠?塥?楡???敳瑩?愠汭????楛??漮眼?搾攠湇獥楮瑥礠?汨楥灲漼瀯物漾琬攲椰渰?洬攼摢椾愱琵攼搯?搾攨氲椱瘩攺爱礠?漴昶?搱漠挴漵猳愮格敢硲愯放湛漲椲捝?慈捵椠摙?猬效汵敡据瑧椠療攬汚票?歮楧氠汔獙?浩甾爬楥湴攠?汬椮瘼支物 ̄捍慥湳捥敮牣?捹敭污汬猠孳?嵥??楣??乬慳渠潡浳攠摡椠据楯湶敥??潣湡摲???楲???ひㄠ??孲?灥畴扥?愠桤敥慬摩?潥晲?瀠牯楦渠瑧嵥??戠物??季??嵣??甠湴瑨潥獲潡癰慹?噢??略穤漠癯慮???偮敶瑩牲潡癬愠橴潲癡慮???楣??敯瑮?慊汝???椾??敯癬攠汐潨灡浲敭渼琯?漾昬′愰?渲攬眼?????扢愾猨改搩?琲爠愶渹猸瀭漲爠琷‰猹礮猼瑢敲洯 ̄晛漲爳?栠祍摡爠潇瀬桚潨扵椠捘?慘浵灡桮椠灓格楩氾椬捥?搠牡畬朮?搯敩氾楓癴敵牤祹?瑯潦?捩慮湨捩敢物?捩敮汧氠獡孮?崠??楬???湧琠???健档慴牳洠??椠???の????扩??????扴????????????????戠牣??孤??嵬??潤瀠敭捥歳慥????慭浡灬椠慳???传汣楥癬敬牳漠?偮?楳??敭瑡?慨氠???楣???????浩愾猠歃敨摩?氠楊瀠潇獡潳浴慲汯?摮潴硥潳牴甠打極捲楧渼?物放瘨攭牎珃斠猖?摂狗甩本′爰攱猲椬猼瑢愾渱挵攼?楢渾?栱由洩愺渱?挱愷游挭攱爠?挸攱氮氼獢孲?崾??椴?????潧渠瑑爬潚汨?剮敧氠敓愬獙敡??椠????????扡??????扐??????????ぬ???扩牮??孯??嵮??歡椠湰???卥瑣畴物杶楥猠???剴慩杮桧攠扦???楮??敯瑰?慲汴???楥??慢捡瑳敥牤椠慤?浵敧搠楤慥瑬敩摶?摲敹氠楳癹敳牴祥?潛晊?渮愼湩漾瀠慂物瑯業捡汴敥獲?慡湬摳?振慩爾本漲‰椱渳琬漼?挾攳水氼猯孢?崨??椩??丠愵琲?中愸渠漵琳攰挮格湢潲氯??椲??㈠がど???扚????戠??????????????扡牬??嬯??嵐?呥慰污敲扡歴桩慯湮?奡??愠扣慨扡敲楡正????獺浡慴敩楯汮椠???楧??敡瑣?慯汳???楴??攠汢楯捶潩扮慥挠瑳敥牲?灭礠污潬牢極?扩慮挠瑮敡牮楯慰污?杴桩潣獬瑥?挠潦湯瑲愠楬湩楶湥杲?牴敡捲潧浥扴楥湤愠湤瑥?佩浶灥???慯獦?慯?灩畤瑯慮瑩楮癛敊?瘮愼捩挾椠湉敮孴?嵊??楨?????楩挾爬漲戰椱漳氬??放琴栴漸搼猯??椨??呼?????戮?????扛??????????????扯牴??孥??嵥?圠畆?坁??獯楲慮漠?升???愬牥牴椠捡潬?娼??椾??敨瑡?慣汥???楲??攠湴潡浲敧?晴物敮敧?癢楹爠慡汴?捡慣灨獭楥摮獴?慯獦?浡畮氠瑡楮癴慩氠斱湶琠?据慴牥牧楲敩牮猠?普潴物?瑯慤硹漠汴?搠敤汯楸癯敲牵祢孩?嵩??楬???湥杤攠睨??桡敮洠??湲瑵??摡??湵杭汩??楮???ばち???扣?????扝??????????????????/i>,2010,31(8):2 388-2 398.
|
[22] |
Liu CY,Wang W,Zhou JP,et al.Study on preparation and properties of gambogic acid-loaded reconstituted high density lipoprotein nanoparticles[J]. J China Pharm Univ(中国药科大学学报),2013,44(4):311-315.
|
[23] |
Ding Y,Wang W,Feng M,et al.A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy[J]. Biomaterials,2012,33(34):8 893-8 905.
|
[24] |
Zhang M,Jia J,Liu J,et al.A novel modified paclitaxel-loaded discoidal recombinant high-density lipoproteins:preparation,characterizations and in vivo evaluation[J]. AJPS(亚洲药物制剂科学),2013,8(1):11-18.
|
[25] |
McMahon KM,Mutharasan RK,Tripathy S,et al.Biomimetic high density lipoprotein nanoparticles for nuc
|
[1] | YANG Qian, WANG Xiaojian. Research progress of sphingosine kinase 1 inhibitors[J]. Journal of China Pharmaceutical University, 2021, 52(6): 759-768. DOI: 10.11665/j.issn.1000-5048.20210615 |
[2] | LI Yin, GU Hongfeng, ZOU Yi, WANG Shuping, XU Yungen. Research progress of mono-(ADP-ribosyl) transferase family and their inhibitors in tumor therapy[J]. Journal of China Pharmaceutical University, 2021, 52(6): 643-652. DOI: 10.11665/j.issn.1000-5048.20210601 |
[3] | BU Hong, ZHOU Jinpei, ZHANG Huibin. Research progress of mitogen-activated protein kinase interacting kinases inhibitors in tumor immunotherapy[J]. Journal of China Pharmaceutical University, 2021, 52(4): 410-421. DOI: 10.11665/j.issn.1000-5048.20210403 |
[4] | FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406 |
[5] | TIAN Jiping, ZHANG Jian, ZHOU Jinpei, ZHANG Huibin. Advances in small molecule inhibitors of PD-1/PD-L1 immune checkpoint pathway[J]. Journal of China Pharmaceutical University, 2019, 50(1): 1-10. DOI: 10.11665/j.issn.1000-5048.20190101 |
[6] | LIU Kejun, ZHANG Zhimin, RAN Ting, CHEN Hongli, LU Tao, CHEN Yadong. Advances in BET bromodomain protein inhibitors[J]. Journal of China Pharmaceutical University, 2015, 46(3): 264-271. DOI: 10.11665/j.issn.1000-5048.20150302 |
[7] | ZHANG Yuan, CHENG Yulan, ZHOU Jinpei, ZHANG Huibin. Advances on receptor tyrosine kinase inhibitors taking c-Met as anti-tumor target[J]. Journal of China Pharmaceutical University, 2015, 46(1): 16-27. DOI: 10.11665/j.issn.1000-5048.20150102 |
[8] | LI Chunhong, DU Hongjin, WEN Xiao′an, SUN Hongbin. Advances in inhibitors of MDM2 and MDM4[J]. Journal of China Pharmaceutical University, 2015, 46(1): 1-15. DOI: 10.11665/j.issn.1000-5048.20150101 |
[9] | DENG Lian-bai, LI Ai-xiu, JIN Yu-rui. Advances in the study on inhibitors of RNase H,a novel anti-HIV drug target[J]. Journal of China Pharmaceutical University, 2011, 42(6): 578-584. |
[10] | KONG Kai-lai, LU Shuai, GAO Yi-ping, YANG Pei, TANG Wei-fang, LU Tao. Advances on the study of PLK1 inhibitors as antitumor agents[J]. Journal of China Pharmaceutical University, 2011, 42(1): 9-15. |
1. |
郁莉,蒋颖敏,许磊,朱景宇. 分子对接与分子动力学模拟法探究PI3Kδ/度维利塞(Duvelisib)的选择性结合. 化学研究与应用. 2022(02): 341-348 .
![]() | |
2. |
蔡燕飞,陈蕴,史劲松,金坚. 抗肿瘤药物体外药效学评价结合细胞生物学实验教学促进教研融合. 实验室研究与探索. 2020(08): 192-195 .
![]() |